Integrated Nano-Technologies

Integrated Nano-Technologies (INT) is a biotechnology company that develops advanced diagnostic systems for the rapid and sensitive detection of nucleic acids. The company's flagship Palladium platform utilizes a proprietary electronic DNA detection technology that eliminates the need for traditional PCR amplification and complex laboratory infrastructure. By leveraging the unique electrical properties of DNA and metalization processes, INT provides point-of-care solutions capable of identifying pathogens in less than 30 minutes. Their product portfolio focuses on infectious diseases, including COVID-19 and respiratory viruses, as well as biodefense and environmental monitoring applications. Headquartered in Henrietta, New York, INT serves clinical, field, and industrial markets with its portable and automated diagnostic tools.